These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12006603)

  • 21. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
    Read J; Suphioglu C
    Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Affinity Binding of Monomeric but Not Oligomeric Amyloid-β to Ganglioside GM1 Containing Nanodiscs.
    Thomaier M; Gremer L; Dammers C; Fabig J; Neudecker P; Willbold D
    Biochemistry; 2016 Dec; 55(48):6662-6672. PubMed ID: 27933798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell surface proteoglycan-mediated uptake and accumulation of the Alzheimer's disease peptide Aβ(1-42).
    Wesén E; Gallud A; Paul A; Lindberg DJ; Malmberg P; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2204-2214. PubMed ID: 30409516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
    Smith LM; Strittmatter SM
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.
    Van Muiswinkel FL; Raupp SF; de Vos NM; Smits HA; Verhoef J; Eikelenboom P; Nottet HS
    J Neuroimmunol; 1999 Apr; 96(1):121-30. PubMed ID: 10227431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β.
    Ma JW; Zhao L; Zhao DS; Liu Q; Liu C; Wu WH; Chen YX; Zhao YF; Li YM
    Chem Commun (Camb); 2012 Nov; 48(85):10565-7. PubMed ID: 23001350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased insulin-receptor signaling promotes the autophagic degradation of beta-amyloid peptide in C. elegans.
    Florez-McClure ML; Hohsfield LA; Fonte G; Bealor MT; Link CD
    Autophagy; 2007; 3(6):569-80. PubMed ID: 17675890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
    J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model.
    Lin F; Jia J; Qin W
    Neuroreport; 2014 Nov; 25(16):1289-95. PubMed ID: 25202927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release.
    Michikawa M; Gong JS; Fan QW; Sawamura N; Yanagisawa K
    J Neurosci; 2001 Sep; 21(18):7226-35. PubMed ID: 11549733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
    Mandal PK; Pettegrew JW
    Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease.
    Padayachee ER; Whiteley CG
    Biochim Biophys Acta; 2011 Dec; 1810(12):1136-40. PubMed ID: 21930189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.
    Walsh DM; Hartley DM; Condron MM; Selkoe DJ; Teplow DB
    Biochem J; 2001 May; 355(Pt 3):869-77. PubMed ID: 11311152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aβ-Induced Insulin Resistance and the Effects of Insulin on the Cholesterol Synthesis Pathway and Aβ Secretion in Neural Cells.
    Najem D; Bamji-Mirza M; Yang Z; Zhang W
    Neurosci Bull; 2016 Jun; 32(3):227-38. PubMed ID: 27207326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.